Pelvic examination leads to changed clinical management in very few women diagnosed with asymptomatic chlamydia infection
Yi Man Lee A B , Anil Samaranayake B D , Christopher K. Fairley B C , Marcus Y. Chen B , Fiona MacFarlane B , Catriona S. Bradshaw B and Jane S. Hocking A EA Centre for Women’s Health, Gender and Society, University of Melbourne, 2/723 Swanston Street, Carlton, Vic. 3053, Australia.
B Melbourne Sexual Health Centre, 580 Swanston Street, Carlton, Vic. 3053, Australia.
C Melbourne School of Population Health, University of Melbourne, 5/207 Bouverie Street, Carlton, Vic. 3053, Australia.
D Ministry of Health, Colombo, Sri Lanka.
E Corresponding author. Email: jhocking@unimelb.edu.au
Sexual Health 7(4) 498-499 https://doi.org/10.1071/SH09074
Submitted: 15 July 2009 Accepted: 24 March 2010 Published: 10 November 2010
Abstract
The present study aimed to determine whether pelvic examinations change clinical management of women with asymptomatic chlamydia infection. Records for women with asymptomatic chlamydia who underwent a pelvic examination at a sexual health clinic in Melbourne, Australia (January 2006 to June 2007) were analysed retrospectively. Of 91 cases, 31 (34%) warranted examination; one woman (1%; 95% confidence interval: 0.5%, 6.4%) had muco-purulent cervicitis and mild tenderness, and was treated for possible pelvic inflammatory disease. These data suggest that a pelvic examination will lead to changes in treatment for very few women diagnosed with asymptomatic chlamydia infection.
Additional keywords: pelvic inflammatory disease, treatment.
[1] Hocking JS, Walker J, Regan D, Chen MY, Fairley CK. Chlamydia screening – Australia must strive to achieve what others have not. Med J Aust 2008; 188 106–8.
| PubMed |
![](../../media/share/OpenURL_Image.gif)
[2] Peipert JF. Clinical practice. Genital chlamydial infections. N Engl J Med 2003; 349 2424–30.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |
![](../../media/share/OpenURL_Image.gif)
[3] Lau C-Y, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections. A meta-analysis of randomized clinical trials. Sex Transm Dis 2002; 29 497–502.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |
![](../../media/share/OpenURL_Image.gif)
[4]